To market new drugs in India, global trials must include Indians Ruby Khatun Khatun12 Oct 2017 3:21 PM ISTNew Delhi: The drug regulator in a recent technical committee meeting, headed by Jagdish Prasad, Director General of Health Services, has made it...
Roche Perjeta regimen gets FDA priority review in breast cancer Ruby Khatun Khatun4 Oct 2017 9:20 AM ISTZURICH: The U.S. Food and Drug Administration (FDA) has granted a priority review for Roche's Perjeta in combination with Herceptin and chemotherapy...
Bristols drug cocktail cuts kidney cancer death risk 37 percent Ruby Khatun Khatun14 Sept 2017 9:25 AM ISTMADRID: A combination of two Bristol-Myers Squibb immunotherapy drugs cut the risk of death by 37 percent in a key group of kidney cancer patients,...
AstraZeneca rebuilds cancer drug hopes with new lung data Ruby Khatun Khatun12 Sept 2017 9:32 AM ISTMADRID: Two AstraZeneca drugs tackling lung cancer in different ways delivered encouraging results on Saturday, helping the British group offset...
